- Khan NH, Messenger LA, Wahid S, Sutherland CJ. Phylogenetic position
of Leishmania isolates from Khyber Pakhtunkhwa province of Pakistan. Exp Parasitol. 2016;
24(167): 61-66.
2. Sarkari B, Ahmadpour NB, Motazedian MH, Mirjalali H, Akhoundi M, Mohebali M, Hajjaran
H. Inter- and intraspecific variations of Leishmania strains isolated from patients with
cutaneous and visceral leishmaniases in Fars province, south of Iran. Iran J Med Sci. 2016; 41
(3): 209-216.
3. Radosavljevic J, Naimov S. Toxicity of Bacillus thuringiensis Cry proteins against summer fruit
tortrix (adoxophyes orana-fischer von rösslerstamm). J Invertebr Pathol. 2016; 14(138): 63-65.
4. Sobel JD, Nyirjesy P, Brown W. Tinidazole therapy for metronidazole-resistant Vaginal
trichomoniasis. Clin Infect Dis. 2001; 33: 1341-1346.
5. zbi gin , arman , Kara uş , ar , oz , Kur , Ça uş , o a E, Gun uz C, an
Gool T, Ozbel Y. Leishmaniasis in Turkey: Visceral and cutaneous leishmaniasis caused
by Leishmania donovani in Turkey. Acta Trop. 2017; 173: 90-96.
6. Ul Bari A. Chronology of cutaneous leishmaniasis: an overview of the history of the disease. J
Prev Alzheimer's Dis. 2006; 16: 24-27.
7. Lainson R. The neotropical leshmania species: a brief historical review of their discovery
ecology and taxonomy. Rev Pan –Amaz Saude. 2010; 2: 13-32.
8. Hanan A, El-Sadawy H, Abou El-Hag A, Janette M, Shaaban S, Hala A. In vitro activity of
Bacillus thuringiensis (H14) 43 kDa crystal protein against Leishmania major. J Agric Environ
Sci. 2008; 3(4): 583-589.
9. Santana MA, Moccia CC, Gillis AE. Bacillus thuringiensis improved isolation methodology
from soil samples. J Med Microbiol. 2008; 75: 357-358.
10. Rampersad J. Ammons D. Bacillus thuringiensis isolation method utilizing a novel stain, low
selection and high throughput produced atypical result. BMC Microbiol. 2005; 24(5): 52.
11. Moazamian E, Bahador N, Rasouli M, Azarpira N. Ubiquity of parasporin producers in
Bacillus thuringiensis natural population of Iran. Healthmed. 2012; 7(3): 971-975.
12. Brasseur K, Auger P, Asselin E, Parent S, Cote JC, Sirois M. parasporin-2 from a new Bacillus
thuringiensis 4r2 strain induces caspases activation and apoptosis in human cancer cells. PLoS
One. 2015; 10(8): 135.
13. Daneshbod Y, Oryan A, Davarmanesh M, Shirian S, Negahban S, Aledavood A, Davarpanah
MA, Soleimanpoor H, Daneshbod K. Clinical, histopathologic, and cytologic diagnosis of
mucosal leishmaniasis and literature review. Arch Pathol Lab Med. 2011; 135(4): 478-482.
14. Biazar S, Moazamian E, Azarpira N. Cytocidal effects of Bacillus thuringiensis crystal protein
on mice breast cancer cell line in in vitro condition. J Cell Tissue. 2017; 3: 243-250.
15. Porcar M, Deleclusse A, Ibarra JE, Juarez-Perez V. Early transcription of Bacillus
thuringiensis cry genes in strains active on lepidopteran species and the role of gene content on
their expression. Antonie Van Leeuwenhoek. 2014; 105(6): 1007-1115.
16. Okassov A, Nerseyan A, Kitada S, Ilin A. Parasporins as new natural anticancer agents.
J Balkan Union Oncol. 2015; 20(1): 5-16.
17. Armijos RX. Weigel MM. Calvopina M. Hidalgo A. Cevallos W. Correa J. Safety,
immunogenecity, and efficacy of an autoclaved Leishmania amazonensis vaccine plus bcg
adjuvant against new world cutaneous leishmaniasis. Vaccine. 2004; 22: 1320-1326.
18. Moazamian E, Bahador N, Rasouli M, Azarpira N. Isolation, characterization and serotype
classification of Bacillus thuringiensis from different soil samples of Fars province. J Microb
World. 2010; 3: 24-30 [In Persian].
19. Moazamian E, Bahador N, Rasouli M, Azarpira N, Kalani M. Investigation of cytocidal
activity of Bacillus thuringiensis parasporal toxin on CCRF-CEM cell line. J Fasa
Univ Med Sci. 2012; 2(4): 247-253.
20. Poornima K, Selvanayagam P, Shenbagarathai R. Identification of native Bacillus
thuringiensis strain from South India having specific cytocidal activity against cancer cells. J
Appl Microbiol. 2010; 109: 348-354.
21. Mizuki E, Park YS, Saitoh H, Yamashita S, Akao T, Higuchi K, Ohba M. Parasporin, a human
leukemic cell-recognizing parasporal protein of Bacillus thuringiensis. Clin Diagn Lab
Immunol. 2000; 7(4): 625- 634.
22. Park HW, Bideshi DK, Federici BA. Molecular genetic manipulation of truncated Cry 1c
protein synthesis in Bacillus thuringiensis to improve stability and yield. Appl
Environ Microbiol. 2000; 66: 4449-4455.
23. Kondo S, Mizuki E, Akao T, Ohba M. Antitrichomonal strains of Bacillus thuringiensis.
Parasitol Res. 2002; 88: 1090-1092.
24. Cappello M, Bungiro RD, Harrison LM. A purified Bacillus thuringiensis crystal protein with
therapeutic activity against the hookworm parasite Ancylostoma ceylanicum. Proc Natl Acad
Sci USA. 2006; 103: 15154-15159.
25. Desjeux P. Leishmaniasis: current situation and new perspectives. Europ J Clin Microbiol
Infect Dis. 2004; 27: 305-318
|
